Hydrochlorothiazide and Weight Change
Hydrochlorothiazide (HCTZ) can cause short-term weight loss related to fluid loss from diuresis, particularly in settings such as acute heart failure. [1] In broader outpatient comparisons, HCTZ has not consistently been associated with meaningful long-term weight loss and may be associated with small weight increases compared with some alternatives. [2]
Mechanism of Weight Change
HCTZ increases urinary sodium and water excretion, which can reduce body fluid volume and produce early decreases in measured body weight. [1] This weight change reflects mostly fluid loss rather than loss of body fat. [1]
Evidence From Heart Failure Studies
In acute decompensated heart failure trials, HCTZ added to loop diuretics has been associated with improved short-term weight loss as an efficacy marker of decongestion. [1] Post-hoc analyses in this setting showed that the treatment effect of HCTZ on weight change was broadly similar across diuretic-resistance strata. [3]
Evidence From Routine Antihypertensive Use
In an emulated target-trial analysis of 141,260 adults initiating antihypertensive monotherapy, the estimated 6-month weight change under HCTZ was higher than under lisinopril (difference vs lisinopril: +0.68 kg, 95% CI 0.31 to 1.04). [2] In the same analysis, weight changes under different antihypertensive drugs were small overall. [2]
Short-Term Magnitude in Diuretic-Resistance Populations
In a network meta-analysis of randomized trials for diuretic resistance in heart failure, HCTZ produced among the largest standardized reductions in 72-hour weight change compared with other add-on strategies. [4] The network meta-analysis also reported increased acute kidney injury signals for HCTZ in the studied comparisons, supporting the need for monitoring rather than weight-loss intent. [4]
Clinical Interpretation
HCTZ can reduce measured weight over days when fluid retention is being treated. [1] HCTZ is not established as a reliable cause of clinically meaningful weight loss over months in general outpatient populations. [2]
Adverse-Effect Considerations
HCTZ use is associated with electrolyte changes such as hypokalemia risk in contexts where it is combined with other diuretics and where baseline abnormalities may be present. [1] These risks support avoiding use of HCTZ for weight loss as a primary goal. [1]
When Weight Change Should Be Evaluated
Rapid weight loss after starting or escalating HCTZ can reflect effective diuresis but may also coincide with volume depletion, electrolyte abnormalities, or renal function changes that warrant clinical reassessment. [4]